In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Biopharma Sizes Up The Affordable Care Act: Buyer’s Remorse Or Winner’s Curse?

Executive Summary

Three years into the ACA, the biopharma industry takes stock of its near-term wins and losses as the law’s critical expanded insurance coverage takes effect beginning in 2014. Pharma still isn’t sure whether the increase in covered lives from the exchanges will boost prescription sales enough to offset the rebates, taxes, and fees it agreed to pay out, or what kind of patients constitute this new market.

Advertisement

Related Content

Assessing The Sales Impact Of The New Health Insurance Exchange Market
New Insurance Marketplaces Won’t ‘Move The Needle’ Near-Term For Pharma Economics – An Interview With Booz & Co.
Takeda Treads Carefully With DPP-4 Late-Arrival Nesina, Plans Summer Launch
GSK’s New Commercial Model Will “Stay The Course” Regardless Of ACA’s Future
Biopharmaceuticals Beyond The Drug: Changing Pharma's Value Proposition
Pharma Plus: Merck’s Global Health Innovation Fund
Price Controls in Action: Understanding the Rise of the 340B Program
Opening A Door To Biosimilars In The US
Pharma Industry Likely To Take Wait-And-See Approach To GSK U.S. Sales Incentive Changes
Personalizing Patient Care:Sanofi Recasts Its Diabetes Efforts

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

IV004067

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel